ChenH.GuoJ.WangC.LuoF.YuX.ZhangW.LiJ.ZhaoD.XuD.GongQ.LiaoJ.YangH.HouW.ZhangY. (2020). Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet, 395(10226), 809–815.doi:10.1016/S0140-6736(20)30360-3http://www.ncbi.nlm.nih.gov/pubmed/32151335
2.
DarnellM. E. R.TaylorD. R. (2006). Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion, 46(10), 1770–1777.doi:10.1111/j.1537-2995.2006.00976.xhttp://www.ncbi.nlm.nih.gov/pubmed/17002634
RabenauH. F.CinatlJ.MorgensternB.BauerG.PreiserW.DoerrH. W. (2005). Stability and inactivation of SARS coronavirus. Medical Microbiology and Immunology, 194(1-2), 1–6.doi:10.1007/s00430-004-0219-0http://www.ncbi.nlm.nih.gov/pubmed/15118911
8.
van DoremalenN.BushmakerT.KareshW. B.MunsterV. J. (2014). Stability of middle East respiratory syndrome coronavirus in milk. Emerging Infectious Diseases, 20(7), 1263–1264.doi:10.3201/eid2007.140500http://www.ncbi.nlm.nih.gov/pubmed/24960335